Table 3 Clinical indicators of IVF-ET of follicular fluid samples
From: Clinical significance and biological roles of lncRNA CTBP1-AS in polycystic ovary syndrome
Clinical indicators | PCOS(N = 13) | Control(N = 17) | t / Z / χ2 | p value |
|---|---|---|---|---|
Gn Days of use(d) | 9(9, 10) | 10(10,12) | 2.329 | 0.022* |
Total Gn(IU) | 1550(1200, 1562) | 2125(1775,2575) | 3.440 | < 0.001* |
HCG days | ||||
Endometrial thickness(mm) | 11.0(11.0, 12.5) | 11.0(10.0, 12.5) | 0.021 | 0.983 |
E2(pg/mL) | 4082.46 ± 1997.17 | 3379.39 ± 1194.54 | 1.201 | 0.240 |
No. of oocytes retrieved(n) | 20.15 ± 4.93 | 12.18 ± 4.49 | 4.623 | < 0.001* |
No. of MII oocytes(n) | 15.08 ± 5.01 | 9.35 ± 3.84 | 3.548 | 0.001* |
Number of fertilized(n) | 11(7, 19) | 9(6, 11) | 1.643 | 0.100 |
No. of cleavage embryos(n) | 10(7, 18) | 9(5, 11) | 1.368 | 0.171 |
No. of good-quality embryos(n) | 7(5, 8) | 4(3, 5) | 2.147 | 0.035* |
OHSS occurrence rate (%) | 46.2(6/13) | 11.8(2/17) | 4.455 | 0.045* |
Transplant cancellation rate (%) | 46.2(6/13) | 29.4(5/17) | 0.889 | 0.287 |
Pregnancy rate (%) | 42.9(3/7) | 41.7(5/12) | 0.003 | 0.663 |